Empowering investors with access to the best research, experts and opportunities.
22nd April 2025
22nd May 2025
16th May 2024
Live Investor Briefing
In this session Felix Gold Executive Director Joseph Webb discussed their plans to develop a potential multi million ounce high grade gold resource.
Speaker
DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)
18th April 2024
In this session Far East Gold’s CEO and Director Shane Menere discussed the standout assays from our Woyla drilling campaigns that form the base of our upcoming maiden JORC resource publication.
9th April 2024
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed why the data from their PTX-100 Phase 1b trial is so promising.
25th March 2024
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke provide a company update on strategy and upcoming milestones.
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
14th March 2024
Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.
22nd February 2024
In this session Far East Gold’s CEO and Director Shane Menere discussed, why the Board (including Nickel Industries MD Justin Werner) is optimistic about the findings so far……
15th February 2024
In this session Wellnex Life MD Zack Bozinovski and Non-Executive Chairman Mario Tascone discussed what attracted Mario to Wellnex and where he sees the future of the business;
24th July 2020
AppsVillage (ASX: APV) Webcast Replay AppsVillage (ASX: APV) provides an easy and inexpensive SAAS solution that allows small-to-medium businesses to create and manage their own mobile application as a means of connecting with their customers and growing their business. AppsVillage’s...
23rd July 2020
Gold Investment Webcast Replay Learn how you can gain exposure into gold and how this investment can benefit during market and economic uncertainty. Recorded on 22 July 2020 at 7pm (AEST). Learn more about this investment opportunity Book into the...
22nd July 2020
Core Lithium (ASX: CXO) is well positioned to be Australia’s next lithium producer, developing one of Australia’s most capital efficient and lowest cost spodumene lithium projects located near Darwin Port in the Northern Territory.
Meet the CEOs Webcast Replay This week we were joined by the CEOs of exciting ASX listed businesses, who gave valuable insight to their industries and companies future prospects. Shane Sikora, from Rumble Resources (ASX: RTR) Ray Shorrocks, from Auteco...
21st July 2020
Credit Intelligence (ASX: CI1) Webcast Replay Credit Intelligence Limited (ASX. CI1) is one of the leading diversified debt-restructuring and personal insolvency management services operating in Hong Kong in the credit funding sector. The company is actively looking to grow its...
16th July 2020
Gold Investment Webcast Replay Learn how you can gain exposure into gold and how this investment can benefit during market and economic uncertainty. Recorded on 15 July 2020 at 7pm (AEST). Learn more about this investment opportunity Book into the...
15th July 2020
Meet the CEOs Webcast Replay This week join the CEOs of exciting ASX listed businesses, they will be giving valuable insight to their industries and companies future prospects. Peter Cook, from Westgold Resources (ASX: WGX) Recorded on 15th July 2020...
9th July 2020
Gold vs S&P500 Investment Webcast Replay Are you bullish on the S&P500 or precious metals like Gold? This investment allows you to gain exposure to both assets and is structured to ensure you receive returns on the best performing asset...
8th July 2020
Meet the CEOs Webcast Replay This week join the CEOs of exciting ASX listed businesses, they will be giving valuable insight to their industries and companies future prospects. Graham Kelly, from Noxopharm (ASX: NXO) Max Bluvband, from AppsVillage (ASX: APV)...
Noxopharm (ASX: NXO) is an Australian-based, clinical stage drug development company which focuses on two areas of drug technology.
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.